BAM-15
BAM-15 is a mitochondrial uncoupling compound studied in preclinical research for its potential to increase energy expenditure without the severe mitochondrial membrane depolarization associated with older uncoupling agents. Animal studies have reported increased metabolic rate and resistance to diet-induced weight gain. There is essentially no published human clinical trial data, and it is not an approved or clinically validated weight-management therapy. It remains a subject of early-stage laboratory and animal research.
Reported benefits
- Increased energy expenditure reported in animal studies
- Resistance to diet-induced weight gain observed in preclinical models
- Proposed improved safety margin relative to older mitochondrial uncouplers, based on animal data
- Distinct mechanism from incretin- and appetite-based weight agents
How it works
BAM-15 mildly uncouples mitochondrial oxidative phosphorylation from ATP production, causing cells to burn additional substrate (fat and glucose) to generate heat rather than usable energy, without collapsing the mitochondrial membrane potential as older uncouplers such as DNP did. This is proposed to raise overall energy expenditure while avoiding some of the acute toxicity associated with earlier uncoupling agents, based on animal studies.
Dosing ranges
| Tier | Dose | Frequency |
|---|---|---|
| Low | 25 mg | once daily (animal-derived estimate; not established in humans) |
| Moderate | 50 mg | once daily (animal-derived estimate; not established in humans) |
| High | 100 mg | once daily (animal-derived estimate; not established in humans) |
Estimate your dose
Dose estimator
Educational estimate for BAM-15, scaled to body size. Not medical advice.
Read before using
This tool produces a rough, educational estimate by scaling commonly-published research ranges to lean body mass. It is not a prescription, medical advice, or a substitute for a licensed clinician. Most peptides use fixed dosing, not weight-based dosing. Individual needs vary. You are solely responsible for how you use this information.
Mixing & syringe units
Target dose follows the estimate above. Change it there, or edit it directly below.
Reconstitution calculator
How much water to add and how many insulin-syringe units to draw for BAM-15. Educational only.
Draw to this mark
1,000units
= 10 mL for a 50 mg dose
Concentration
5 mg/mL
Doses per vial
0
This dose needs 1,000 units, more than a 100-unit syringe holds. Add more water, split the dose, or use a larger syringe.
A U-100 syringe reads 100 units per mL. This is a reconstitution math helper only, not a prescription or dosing advice. Verify every calculation and consult a qualified healthcare provider.
Possible side effects
Stacking notes
Not established; no controlled human data exist on combination with other metabolic agents.
Common protocols
Common questions
What is BAM-15 used for?
BAM-15 is a mitochondrial uncoupling compound studied in preclinical research for its potential to increase energy expenditure without the severe mitochondrial membrane depolarization associated with older uncoupling agents. Animal studies have reported increased metabolic rate and resistance to diet-induced weight gain. There is essentially no published human clinical trial data, and it is not an approved or clinically validated weight-management therapy. It remains a subject of early-stage laboratory and animal research. Reported benefits include increased energy expenditure reported in animal studies, resistance to diet-induced weight gain observed in preclinical models, proposed improved safety margin relative to older mitochondrial uncouplers, based on animal data.
What is a typical BAM-15 dose?
Reported ranges run 25-100 mg. A low protocol is 25 mg once daily (animal-derived estimate; not established in humans), and a high protocol is 100 mg once daily (animal-derived estimate; not established in humans). This is reference information, not a dosing recommendation.
What is the half life of BAM-15?
Not established in humans; preclinical pharmacokinetic data are limited. That is what sets the dosing frequency, and it is why the timing guidance is morning.
How is BAM-15 administered?
Oral: by mouth. Human dosing has not been established; available data come almost entirely from animal and cell-based studies.
How long is a BAM-15 cycle?
No established human protocol on, followed by No established human protocol off. All available dosing information is extrapolated from animal studies and should not be treated as validated for human use.
What are the side effects of BAM-15?
Reported side effects include human safety profile is not established, theoretical risk of excessive metabolic stress or hyperthermia based on the mitochondrial uncoupling mechanism, unknown interaction risk with other metabolic or cardiovascular medications, long-term effects in humans have not been studied. Evidence level for this compound is emerging research.
Partner offer · $20 off
When did you last
check your blood work?
Regular blood work catches changes early. At-home collection with free pickup, 50+ biomarkers, and results in 72 hours.
- 1Order your kitTakes two minutes online, $20 off with this link.
- 2Collect at homePainless draw with free home pickup, no lab visit.
- 3Results in 72 hours50+ biomarkers with clear optimal ranges.
Partner offer · opens rythm.health
Educational use only, not medical advice. This profile is provided for research and educational purposes. BAM-15 may be a research compound or a prescription medication; nothing here is intended to diagnose, treat, cure, or prevent any disease. Dosing figures reflect commonly-published research ranges, not a prescription. Consult a qualified healthcare provider before making any health decision. Read the full disclaimer →